PTGS2 and melanoma: Consistent with these data, anti-metastatic effects of celecoxib in the current model suggest that COX-2 --which plays a central role in the mechanisms of inflammation, angiogenesis and bone remodeling [42]--, contributed to the prometastatic activation of melanoma cells in the BM microenvironment of healthy mice and, more remarkably, of mice given endotoxins.